ANTI-SYNTHETASE SYNDROME
Clinical trials for ANTI-SYNTHETASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTI-SYNTHETASE SYNDROME trials appear
Sign up with your email to follow new studies for ANTI-SYNTHETASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CAR t cells take on muscle disease: could this be a game changer?
Disease control Recruiting nowThis study tests a new treatment called CABA-201 for people with active inflammatory muscle diseases (myositis). It uses a patient's own immune cells, modified to target and destroy faulty immune cells. The goal is to reduce muscle inflammation and allow patients to stop or lower…
Matched conditions: ANTI-SYNTHETASE SYNDROME
Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Jun 12, 2026 12:02 UTC
-
Patients take the lead: rare disease study asks what research matters most
Knowledge-focused Recruiting nowThis study asks people with rare myositis diseases (and their caregivers) what they think researchers should focus on. Through online surveys and forums, the goal is to create a list of patient-driven research priorities. The study aims to enroll 700 participants worldwide.
Matched conditions: ANTI-SYNTHETASE SYNDROME
Sponsor: Myositis International Health & Research Collaborative Alliance Foundation • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC